TimeScale Financial’s Organon & Co OGN Stock Holding History

TimeScale Financial’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$4.1K	Buy	197 +2	+1%	+$43	﹤0.01%	457
2023 Q1	$4.6K	Buy	195 +2	+1%	+$54	﹤0.01%	430
2022 Q4	$4.51K	Buy	193 +1	+0.5%	+$26	﹤0.01%	393
2022 Q3	$5K	Hold	192	–	–	﹤0.01%	388
2022 Q2	$6K	Sell	192 -53	-22%	-$1.86K	﹤0.01%	346
2022 Q1	$9K	Sell	245 -7	-3%	-$239	﹤0.01%	321
2021 Q4	$8K	Buy	252 +10	+4%	+$326	﹤0.01%	334
2021 Q3	$8K	Sell	242 -19	-7%	-$608	﹤0.01%	338
2021 Q2	$8K	Buy	+261	New	+$8.59K	﹤0.01%	346

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

TimeScale Financial's OGN Position: Q2 2023 in Review

TimeScale Financial increased its Organon & Co (OGN) stake by 1% in Q2 2023, buying an estimated $43 and bringing the position to 197 shares worth $4.1K. The position accounts for ﹤0.01% of the portfolio, ranked #457.

TimeScale Financial first reported a position in OGN in Q2 2021 and has held it in 9 quarters since. The position peaked at $9K in Q1 2022. 727 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

TimeScale Financial held 197 shares of Organon & Co worth $4.1K as of Q2 2023.
TimeScale Financial bought 2 Organon & Co shares in Q2 2023, an estimated $43.
Organon & Co made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #457 holding.
TimeScale Financial first reported a position in Organon & Co in Q2 2021 and has held it in 9 quarters since.
TimeScale Financial's Organon & Co position peaked at $9K in Q1 2022.
727 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.